Search

Author/Creator Comisar, Craig

1. Ceftazidime‐Avibactam Population Pharmacokinetic Modeling and Pharmacodynamic Target Attainment Across Adult Indications and Patient Subgroups. Issue 2 (28th September 2018)

Authors:
Li, Jianguo; Lovern, Mark; Green, Michelle L.; Chiu, Joannellyn; Zhou, Diansong; Comisar, Craig; Xiong, Yuan; Hing, Jeremy; MacPherson, Merran; Wright, James G.; Riccobene, Todd; Carrothers, Timothy J.; Das, Shampa
Journal:
Clinical and translational science
Issue:
Volume 12:Issue 2(2019)
Page Start:
151
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Exposure‐response relationships for the efficacy and safety of filgotinib and its metabolite GS‐829845 in subjects with rheumatoid arthritis based on phase 2 and phase 3 studies. Issue 7 (14th February 2022)

Authors:
Meng, Amy; Anderson, Kacey; Nelson, Cara; Ni, Liyun; Chuang, Shu‐Min; Bellanti, Francesco; Chang, Peter; Comisar, Craig; Kearney, Brian P.; Bartok, Beatrix; Mathias, Anita
Journal:
British journal of clinical pharmacology
Issue:
Volume 88:Issue 7(2022)
Page Start:
3211
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Population pharmacokinetics and exposure‐response of osimertinib in patients with non‐small cell lung cancer. (6th February 2017)

Authors:
Brown, Kathryn; Comisar, Craig; Witjes, Han; Maringwa, John; de Greef, Rik; Vishwanathan, Karthick; Cantarini, Mireille; Cox, Eugène
Journal:
British journal of clinical pharmacology
Issue:
Volume 83:Number 6(2017:Jun.)
Page Start:
1216
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗